CD4 and hepatocellular carcinoma: Drugs such as solanine (CD4+CD25+ Tregs’ proportion decreaser) [47] and astragalus polysaccharides (FOXP3 expression inhibitor) [48] also revealed antitumor enhancement in HCC via Treg suppression.